Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
KOOL [NASD]
Cesca Therapeutics Inc.
Index- P/E- EPS (ttm)-0.38 Insider Own1.20% Shs Outstand40.28M Perf Week6.48%
Market Cap46.32M Forward P/E- EPS next Y-0.38 Insider Trans2.76% Shs Float28.50M Perf Month-4.17%
Income-8.60M PEG- EPS next Q-0.08 Inst Own13.10% Short Float0.81% Perf Quarter-10.85%
Sales16.00M P/S2.90 EPS this Y-89.50% Inst Trans0.55% Short Ratio3.09 Perf Half Y-30.30%
Book/sh1.39 P/B0.83 EPS next Y-20.00% ROA-24.70% Target Price6.00 Perf Year57.53%
Cash/sh0.37 P/C3.13 EPS next 5Y- ROE-31.50% 52W Range0.71 - 3.24 Perf YTD12.75%
Dividend- P/FCF- EPS past 5Y10.00% ROI-17.70% 52W High-64.51% Beta1.28
Dividend %- Quick Ratio3.10 Sales past 5Y-4.20% Gross Margin36.90% 52W Low61.97% ATR0.08
Employees95 Current Ratio4.00 Sales Q/Q-7.30% Oper. Margin-56.30% RSI (14)56.02 Volatility9.19% 7.19%
OptionableNo Debt/Eq0.00 EPS Q/Q42.90% Profit Margin-54.40% Rel Volume0.69 Prev Close1.16
ShortableYes LT Debt/Eq0.00 EarningsSep 25 AMC Payout- Avg Volume74.32K Price1.15
Recom2.00 SMA207.03% SMA50-1.30% SMA200-24.18% Volume51,556 Change-0.86%
Jun-26-14Initiated H.C. Wainwright Buy $5
Apr-24-14Initiated Maxim Group Buy $7
Nov-21-14 04:45PM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta EDGAR Online
01:04PM  CESCA THERAPEUTICS INC. Financials EDGAR Online Financials
Nov-20-14 06:00AM  Cesca Therapeutics Announces Filing of U.S. Pivotal IDE Application for No-Option Critical Limb Ischemia ("CLI") GlobeNewswire +16.00%
Nov-18-14 07:07PM  10-Q for Cesca Therapeutics, Inc. Company Spotlight -5.50%
Nov-14-14 06:02AM  CESCA THERAPEUTICS INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-13-14 05:01PM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:00PM  Cesca Therapeutics Reports First Quarter Fiscal 2015 Results GlobeNewswire
Nov-12-14 06:00AM  Cesca Therapeutics to Announce First Quarter Fiscal 2015 Results on November 13, 2014 GlobeNewswire
Nov-03-14 04:22PM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Oct-30-14 04:26PM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financia EDGAR Online
Oct-29-14 09:00AM  Cesca Therapeutics Announces Change in Executive Leadership GlobeNewswire
Oct-13-14 06:00AM  Cesca Therapeutics Announces Agreement With New York Upstate Cord Blood Bank GlobeNewswire
Oct-06-14 06:00AM  Cesca Therapeutics to Present at Stem Cell Meeting on the Mesa GlobeNewswire
Oct-01-14 08:08PM  10-K for Cesca Therapeutics, Inc. Company Spotlight
Sep-29-14 03:58PM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
06:05AM  Cesca Therapeutics Announces Approval of Its AXP(R) AutoXpress(R) System in Taiwan GlobeNewswire
06:00AM  Cesca Therapeutics Reports Fourth Quarter and Full Fiscal 2014 Results GlobeNewswire
Sep-25-14 04:30PM  Cesca Therapeutics Reschedules Fourth Quarter and Full Year Earnings Release GlobeNewswire
07:07AM  Q4 2014 Cesca Therapeutics Inc Earnings Release - After Market Close CCBN
Sep-23-14 06:00AM  Cesca Therapeutics to Announce Fourth Quarter and Fiscal 2014 Year End Results on September 25, 2014 GlobeNewswire
Sep-10-14 07:00AM  Cesca Therapeutics to Present at Aegis Healthcare & Technology Conference GlobeNewswire
06:00AM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Other Events EDGAR Online
Sep-04-14 06:00AM  Cesca Therapeutics to Present at the Rodman & Renshaw(R) 16th Annual Global Investment Conference GlobeNewswire
Aug-27-14 06:00AM  Cesca Therapeutics Advocates Benefits of Cell Therapy to the Centers for Medicare and Medicaid Services GlobeNewswire
Aug-22-14 06:00AM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Aug-05-14 06:00AM  Cesca Therapeutics and Fortis Healthcare Announce Master Collaboration Agreement GlobeNewswire
Jul-08-14 07:09AM  CESCA Management Provides Regulatory Update on Its Proposed U.S. Pivotal Critical Limb Ischemia Clinical Trial GlobeNewswire
Jun-26-14 09:27AM  Coverage initiated on Cesca Therapeutics by H.C. Wainwright Briefing.com
Jun-16-14 05:27PM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Jun-13-14 08:36AM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial State EDGAR Online -17.51%
08:30AM  Cesca Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants GlobeNewswire
Jun-12-14 04:32PM  Cesca Therapeutics Announces Proposed Public Offering GlobeNewswire
Jun-10-14 09:00AM  Cesca Therapeutics Announces Promising Longer-Term Safety and Efficacy Data on SurgWerks(R)-CLI From the Feasibility Clinical Study GlobeNewswire
Jun-03-14 01:51PM  Cesca Therapeutics to Present at LD Microcap Conference GlobeNewswire
May-23-14 09:00AM  Cesca Therapeutics to Present at the Third Annual Marcum Microcap Conference GlobeNewswire +6.67%
May-21-14 05:09PM  Cesca Therapeutics files $50M mixed securities shelf at theflyonthewall.com
May-15-14 09:07PM  Cesca Therapeutics' (KOOL) CEO Matthew Plavan on Q3 2014 Results - Earnings Call Transcript at Seeking Alpha -6.29%
06:06PM  Cesca Therapeutics reports Q3 EPS (7c) vs. (7c) in Q313 at theflyonthewall.com
05:22PM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:56PM  CESCA THERAPEUTICS INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
04:05PM  Cesca Therapeutics Reports Third Quarter Fiscal 2014 Results GlobeNewswire
May-13-14 09:00AM  Cesca Therapeutics to Announce Third Quarter Fiscal 2014 Results on May 15, 2014 GlobeNewswire
May-12-14 09:00AM  Cesca Therapeutics Announces the Appointment of Dr. Solomon Hamburg to Newly Formed Clinical and Scientific Advisory Board GlobeNewswire
May-01-14 05:02PM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of Inc EDGAR Online
Apr-30-14 09:00AM  Cesca Executive Management Meets With Key Congressional Leaders on the Regenerative Medicine Promotion Act of 2014 GlobeNewswire
Apr-28-14 12:45PM  Senators Support Regenerative Medicine Promotion Act of 2014 Accesswire -7.85%
Apr-24-14 10:59AM  Why Cesca Therapeutics (KOOL) Stock Is Gaining Today at TheStreet +28.75%
10:00AM  On The Fly: Analyst Initiation Summary at theflyonthewall.com
Apr-23-14 06:01AM  CESCA THERAPEUTICS INC. Files SEC form 8-K/A, Financial Statements and Exhibits EDGAR Online
Apr-16-14 09:21AM  Cesca Therapeutics restructures sales and marketing section at theflyonthewall.com
09:10AM  Cesca Therapeutics Announces Sales & Marketing Organizational Restructuring and the Appointment of Industry Veteran Tim Lee as Director of International Sales GlobeNewswire
06:00AM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Mar-26-14 09:15AM  Cesca Therapeutics submits pre-IDE information package to FDA for SurgWerks theflyonthewall.com
09:00AM  Cesca Therapeutics Submits pre-IDE Information Package to FDA for Surgwerks(TM) CLI therapy System GlobeNewswire
Mar-18-14 09:00AM  Cesca Therapeutics to Present at Regen Med Investor Day March 26 in New York GlobeNewswire
Mar-05-14 05:07PM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Mar-03-14 09:15AM  Cesca Therapeutics Appoints Dr. Mahendra Rao to Board of Directors GlobeNewswire
Feb-24-14 09:00AM  Cesca Therapeutics and Cook Medical Enter Supply Agreement for a Phase 1b Clinical Trial GlobeNewswire
Feb-21-14 04:57PM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Unregistered Sale of EDGAR Online -5.14%
Feb-19-14 07:30AM  Cesca Therapeutics Inc., Formerly ThermoGenesis Corp., Closes Merger With TotipotentRX Corporation and Changes Name GlobeNewswire
06:01AM  THERMOGENESIS CORP Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
Feb-17-14 08:29PM  ThermoGenesis' CEO Discusses F2Q2014 Results - Earnings Call Transcript at Seeking Alpha
Feb-14-14 04:23PM  THERMOGENESIS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online -5.65%
04:00PM  ThermoGenesis Corp. Reports Second Quarter Fiscal 2014 Results GlobeNewswire
Feb-13-14 01:50PM  ThermoGenesis Corp. Stockholders Approve Acquisition of TotipotentRX GlobeNewswire +6.48%
Feb-11-14 09:00AM  ThermoGenesis Corp. to Announce Second Quarter Fiscal 2014 Results on February 14, 2014 GlobeNewswire -6.50%
Feb-10-14 02:42PM  Cesca Merger Imminent: Path To 2x+ Returns Appears Achievable at Seeking Alpha +11.82%
Feb-05-14 09:55AM  Thermogenesis Corporation (KOOL) Is Today's Dead Cat Bounce Stock at TheStreet
Feb-03-14 09:20AM  TotipotentRX and ThermoGenesis Achieve Bone Marrow Stem Cell Transplant Milestone GlobeNewswire
Jan-30-14 04:22PM  THERMOGENESIS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi EDGAR Online
Jan-27-14 09:24AM  Thermogenesis raises $6.67M in a private placement theflyonthewall.com -13.12%
09:00AM  ThermoGenesis Corp. Raises $6.67 Million in Private Placement Financing GlobeNewswire
Jan-22-14 12:43PM  Has ThermoGenesis Peaked? at 24/7 Wall St. +14.35%
Jan-21-14 03:33PM  ThermoGenesis Merging With TotiRx - Heating Up Cell Therapy Mergers And Acquisitions at Seeking Alpha +111.01%
09:00AM  TotipotentRX Corporation and ThermoGenesis Corp. Report Statistically Significant Phase Ib Clinical Trial Results in Critical Limb Ischemia GlobeNewswire
Jan-17-14 09:47AM  THERMOGENESIS CORP Files SEC form 8-K, Other Events EDGAR Online
Jan-08-14 09:00AM  ThermoGenesis Signs Direct Supply Agreement With Cord Blood Registry GlobeNewswire +7.62%
Jan-07-14 05:00PM  THERMOGENESIS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
Dec-24-13 06:47AM  Who Will Win The Stem Cell Race? at Seeking Alpha +31.58%
Dec-23-13 12:00PM  ThermoGenesis Announces Bebevida Agreement GlobeNewswire +5.56%
Dec-13-13 05:27PM  THERMOGENESIS CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard EDGAR Online
Nov-27-13 05:18PM  THERMOGENESIS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
Nov-14-13 08:12PM  ThermoGenesis' CEO Discusses F1Q 2014 Results - Earnings Call Transcript at Seeking Alpha
Cesca Therapeutics Inc. focuses on the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. The company develops and manufactures automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. Its products include SurgWerks platform, a proprietary stem cell therapy point-of-care kit systems for treating vascular and orthopedic indications, which integrates various indication specific systems, such as cell harvesting, cell processing and selection, cell diagnostics, and cell delivery; and CellWerks platform for the optimal processing of targeted cells used in the treatment of oncological and hematological disorders. The company also offers MarrowXpress system, which isolates and concentrates stem cells from bone marrow; AXP System, a medical device with a disposable bag set that isolates and retrieves stem cells from umbilical cord blood; and BioArchive System, a robotic cryogenic medical device, which is used to cryopreserve and archive stem cells for future transplant and treatment. In addition, the company provides Res-Q 60 bone marrow concentrate, a centrifuge-based disposable device used for the isolation and extraction of specific stem cell populations from bone marrow; and Res-Q 60 platelet rich plasma (PRP) for the preparation of autologous PRP from a small sample of blood at the point of care. Further, it offers cell manufacturing and banking services. The company sells its products in the United States; Hong Kong, China, and other Asian countries; Europe; South America; and internationally. It was formerly known as ThermoGenesis Corp. and changed its name to Cesca Therapeutics Inc. in February 2014. Cesca Therapeutics Inc. was founded in 1986 and is headquartered in Rancho Cordova, California.